Literature DB >> 19542362

Successful treatment of bacterial infection hinders development of acquired immunity.

Amanda Griffin1, Dahabo Baraho-Hassan, Stephen J McSorley.   

Abstract

Antibiotics are routinely used to control bacterial infection, but the acquisition of acquired immunity following successful treatment has rarely been examined. We developed a model that allows visualization of acquired immunity during and following antibiotic treatment of typhoid. Pathogen-specific humoral and cellular immune responses were activated rapidly in antibiotic-treated mice, but were not sustained after successful antibiotic treatment and did not confer protection to secondary infection. In marked contrast, pathogen-specific Th1 and Ab responses matured over several weeks following immunization with a live vaccine strain. The deficiency in protective immunity following antibiotic treatment could be overcome by administering flagellin during antibiotic therapy. Thus, development of protective immunity is hindered by rapid therapeutic elimination of bacteria, but can be overcome by providing additional inflammatory and/or antigenic stimuli.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542362      PMCID: PMC2706945          DOI: 10.4049/jimmunol.0900772

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Tracking salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection.

Authors:  Stephen J McSorley; Sarah Asch; Massimo Costalonga; R Lee Reinhardt; Marc K Jenkins
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

2.  Repeated antigen exposure is necessary for the differentiation, but not the initial proliferation, of naive CD4(+) T cells.

Authors:  Marc Bajénoff; Olivier Wurtz; Sylvie Guerder
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

3.  Threat of a biological terrorist attack on the US food supply: the CDC perspective.

Authors:  Jeremy Sobel; Ali S Khan; David L Swerdlow
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

Review 4.  Typhoid fever.

Authors:  Christopher M Parry; Tran Tinh Hien; Gordon Dougan; Nicholas J White; Jeremy J Farrar
Journal:  N Engl J Med       Date:  2002-11-28       Impact factor: 91.245

Review 5.  Animal models of Salmonella infections: enteritis versus typhoid fever.

Authors:  R L Santos; S Zhang; R M Tsolis; R A Kingsley; L G Adams; A J Bäumler
Journal:  Microbes Infect       Date:  2001 Nov-Dec       Impact factor: 2.700

6.  Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium.

Authors:  S J McSorley; M K Jenkins
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens.

Authors:  P Mastroeni; C Simmons; R Fowler; C E Hormaeche; G Dougan
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

Review 8.  Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors.

Authors:  Marcela F Pasetti; Myron M Levine; Marcelo B Sztein
Journal:  Vaccine       Date:  2003-01-17       Impact factor: 3.641

Review 9.  Immunity to systemic Salmonella infections.

Authors:  Pietro Mastroeni
Journal:  Curr Mol Med       Date:  2002-06       Impact factor: 2.222

Review 10.  Emerging and reemerging diseases: a historical perspective.

Authors:  Frank M Snowden
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

View more
  20 in total

1.  Dual Immunization with SseB/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells.

Authors:  Seung-Joo Lee; Joseph Benoun; Brian S Sheridan; Zachary Fogassy; Oanh Pham; Quynh-Mai Pham; Lynn Puddington; Stephen J McSorley
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

2.  Generation of Salmonella-specific Th1 cells requires sustained antigen stimulation.

Authors:  Amanda J Griffin; Stephen J McSorley
Journal:  Vaccine       Date:  2011-02-20       Impact factor: 3.641

Review 3.  A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Authors:  Alexander C Maue; Frédéric Poly; Patricia Guerry
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

4.  Direct visualization of endogenous Salmonella-specific B cells reveals a marked delay in clonal expansion and germinal center development.

Authors:  Minelva R Nanton; Seung-Joo Lee; Shaikh M Atif; Sean-Paul Nuccio; Justin J Taylor; Andreas J Bäumler; Sing Sing Way; Stephen J McSorley
Journal:  Eur J Immunol       Date:  2014-11-20       Impact factor: 5.532

5.  Contaminated water delivery as a simple and effective method of experimental Salmonella infection.

Authors:  Hope O'Donnell; Oanh H Pham; Joseph M Benoun; Marietta M Ravesloot-Chávez; Stephen J McSorley
Journal:  Future Microbiol       Date:  2015-10-06       Impact factor: 3.165

6.  Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse.

Authors:  Amanda J Griffin; Lin-Xi Li; Sabrina Voedisch; Oliver Pabst; Stephen J McSorley
Journal:  Infect Immun       Date:  2011-01-24       Impact factor: 3.441

7.  Early eradication of persistent Salmonella infection primes antibody-mediated protective immunity to recurrent infection.

Authors:  Tanner M Johanns; Calvin Y Law; Lokeshchandra A Kalekar; Hope O'Donnell; James M Ertelt; Jared H Rowe; Sing Sing Way
Journal:  Microbes Infect       Date:  2010-12-04       Impact factor: 2.700

8.  Cutting edge: B cells are essential for protective immunity against Salmonella independent of antibody secretion.

Authors:  Minelva R Nanton; Sing Sing Way; Mark J Shlomchik; Stephen J McSorley
Journal:  J Immunol       Date:  2012-11-12       Impact factor: 5.422

Review 9.  Immunity to intestinal pathogens: lessons learned from Salmonella.

Authors:  Stephen J McSorley
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

10.  Comments to metallothionein as an anti-inflammatory mediator.

Authors:  Yong-Song Guan
Journal:  Mediators Inflamm       Date:  2009-10-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.